MIF and urinary bladder cancer: In colocalisation analysis, there was evidence to support shared causal variants across circulating MIF concentrations and bladder cancer risk in the MIF locus (PPH4 = 76.1%), but little evidence to suggest shared causal variants across 5 other inflammatory marker-cancer associations.